Skip to main content

Table 1 Characteristics of samples used in the study

From: Assessment of dengue and COVID-19 antibody rapid diagnostic tests cross-reactivity in Indonesia

Categories Dengue-confirmed samples (N = 60) COVID-19-confirmed samples (N = 95)* Healthy/asymptomatic samples (N = 49)
Fever day onset, mean (SD) 5 (1.5) N/A N/A
Age, median (IQR) 14 (8–22) 34 (25–46) 43 (34–52)
Age N (%)   
Children ≤ 18 years 35 (58) 2 (2.1) 0 (0.0)
Adults > 18 years 25 (42) 78 (82.1) 49 (100)
Gender    
Male 28 (47) 49 (51.6) 34 (69.4)
Female 32 (53) 31 (32.6) 15 (30.6)
Serotype    
DENV-1 15 (25) N/A N/A
DENV-2 15 (25) N/A N/A
DENV-3 20 (33) N/A N/A
DENV-4 10 (17) N/A N/A
Immunologic status    
Primary dengue infection 10 (17) N/A N/A
Secondary dengue infection 50 (83) N/A N/A
Presence of anti-dengue antibodies    
IgG ( +), IgM ( +) 21 (35) N/A N/A
IgG ( +), IgM (−) 16 (27) N/A N/A
IgG (−), IgM ( +) 14 (23) N/A N/A
IgG (−), IgM (−) 9 (15) N/A N/A
  1. *Incomplete data for 15 samples